We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-21.25%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$470M
AUM Growth
-$69.5M
Cap. Flow
+$67.4M
Cap. Flow %
14.35%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
3
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$26.2M
2
RAPT
RAPT Therapeutics
RAPT
+$21.3M
3
RVMD icon
Revolution Medicines
RVMD
+$20.4M

Top Sells

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$454K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$233M 49.49%
18,136,735
+1,890,918
+12% +$26.2M
RVMD icon
2
Revolution Medicines
RVMD
$43.7B
$85.7M 18.23%
4,395,050
+1,047,805
+31% +$20.4M
TNYA icon
3
Tenaya Therapeutics
TNYA
$163M
$52.9M 11.26%
9,400,290
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$48.9M 10.41%
335,057
+159,806
+91% +$21.3M
SRZN icon
5
Surrozen
SRZN
$282M
$27.7M 5.9%
616,542
-11,111
-2% -$454K
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.44B
$16M 3.4%
3,568,181
– –
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$6.12M 1.3%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q2 2022 Portfolio in Review

As of Q2 2022, Column Group held 7 positions worth $470M, down 13% from $539M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group deployed $67.4M of net new capital in Q2 2022, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Surrozen, an estimated $454K trimmed.

  • Column Group added most to NGM Biopharmaceuticals, Inc. Common Stock in Q2 2022, an estimated $26.2M increase.
  • Column Group's biggest Q2 2022 reduction was Surrozen, cutting an estimated $454K.
  • Column Group's ten largest holdings make up 100% of its $470M portfolio in Q2 2022.
  • Column Group opened 0 new positions and closed 0 in Q2 2022.
  • Column Group's portfolio value fell 13% quarter-over-quarter to $470M.

Based on Column Group's 13F filing for Q2 2022, filed 12 Aug 2022.